Back to results
US 2020/0347073 A1Published application
Selective estrogen receptor degraders
AssigneeEli Lilly and Company
InventorsJolie Anne BASTIAN, Jeffrey Daniel COHEN, Almudena RUBIO, Daniel Jon SALL
Life of this patent
Estimating the term…
Abstract
Novel selective estrogen receptor degraders (SERDs) according to the formula: pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, wherein either R1 or R2 is independently selected from Cl, F, —CF3, or —CH3, and the other is hydrogen, and methods for their use are provided.
Claims17
-19. (canceled)
A crystalline form of the compound of the formula:
- wherein either R1 or R2 is independently selected from Cl, F, —CF3, or —CH3, and the other is hydrogen,
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.